...Michael B. Jameson; Stephen O. Evans Chemotherapy Malignancy Radiotherapy Regardless of whether clinicians believe there is any merit to selenium (Se) supplementation in patients with malignancies, it is one of the most common supplements taken by them. The use of Se by cancer...

...T. Kampfenkel; A. Baraniskin; C. Teschendorf; W. Schmiegel; G. Massenkeil Hypercalcemia in malignancies is a frequent complication, mostly affecting patients with solid tumors or multiple myeloma. Calcium elevation is induced by direct bone infiltration of a tumor mass or through calcium liberation...

... patients with advanced malignancy as a phase I/II clinical trial. rhGM-CSF in doses from 30 to 250 μg/m2/day was administered by 24-hour continuous intravenous infusion, 8-hour intravenous, or a daily subcutaneous injection for 14 days. The most common adverse drug events (ADE) were fever, nausea/vomiting...

..., we performed an open nonrandomized clinical trial in 46 patients with malignancies receiving cytotoxic chemotherapy regimen. Twenty-six patients who received two cycles of the identical chemotherapy regimen and had granulocytopenia less than 1 × 10 9 cells/1 after the first cycle of chemotherapy were...

... and there is an increased incidence of neoplasia. Hematologic malignancies associated with this syndrome are, however, unusual. Herein we report a case of Werner’s syndrome with myelodysplastic syndrome, a clonal preleukemic disorder of hemopoietic stem cells. Such an association, to the best of our knowledge, has not been...